To compare the efficacy and tolerability of cyclosporine (CSA) with that of symptomatic therapy (ST) alone and sulfasalazine (SSZ) in the treatment of psoriatic arthritis (PsA).
A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis / Salvarani, C., Macchioni, P., Olivieri, I., Marchesoni, A., Cutolo, M., Ferraccioli, G., Cantini, F., Salaffi, F., Padula, A., Lovino, C., Dovigo, L., Bordin, G., Davoli, C., Pasero, G., Alberighi, O.D.. - In: THE JOURNAL OF RHEUMATOLOGY. - ISSN 0315-162X. - 28:10(2001), pp. 2274-2282.
A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis
SALVARANI, CARLO;
2001
Abstract
To compare the efficacy and tolerability of cyclosporine (CSA) with that of symptomatic therapy (ST) alone and sulfasalazine (SSZ) in the treatment of psoriatic arthritis (PsA).
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
